Last C$0.09 CAD
Change Today 0.00 / 0.00%
Volume 0.0
NPH On Other Exchanges
Symbol
Exchange
Venture
OTC US
As of 2:30 PM 09/22/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Terrance G. Owen Ph.D., MBA

Chief Executive Officer, Principal Financial & Accounting Officer and Director, OICCO Acquisition I, Inc.
AgeTotal Calculated CompensationThis person is connected to 16 board members in 6 different organizations across 11 different industries.

See Board Relationships
68--

Background*

Dr. Terrance G. Owen, Also known as Terry, MBA, Ph.D., has been the Chief Executive Officer of OICCO Acquisition I, Inc. since July 2013 and serves as its Principal Financial & Accounting Officer. Dr. Owen has been the Chief Executive Officer of Nanotech Systems Inc. since May 1, 2012. Dr. Owen has been advising Champion since April, 2012. Dr. Owen served as the Chief Executive Officer and President of Nuva Pharmaceuticals Inc. (alternate name: Alda Pharmaceuticals Corp.) ...

Read Full Background

Corporate Headquarters*

11782 River Road
Richmond, British Columbia V6X 1Z7

Canada

Phone: 604-303-9180
Fax: 604-303-9170

Board Members Memberships*

Former Director
President and Director
Chief Executive Officer, Principal Financial & Accounting Officer and Director
2000-2013
Former Chief Executive Officer, President, Director and Member of Audit Committee
2006-Present
Chairman and Member of Audit Committee
2007-2008
Former Director and Member of Audit Committee
2008-Present
Director, Member of Audit Committee and Member of Compensation Committee
2011-Present
Director and Member of Audit Committee
2013-Present
Director and Member of Audit Committee
2013-Present
Director and Member of Audit Committee

Education*

BS 1968
University Of Victoria
PhD 1974
University Of British Columbia
MBA 1991
Simon Fraser University
MS 1970
University Of New Brunswick, Fredericton

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NPH:CN C$0.09 CAD 0.00

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VANC PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.